A series of 4-aryl-2-(N-ethylanilino)pyrimidines has been synthesized as co
rticotropin-releasing hormone (CRH) inhibitors. The effect of substitution
on each aromatic ring on receptor binding was investigated. (C) 1999 DuPont
Pharmaceuticals. Published by Elsevier Science Ltd. All rights reserved.